China Pharma Holdings (CPHI) Interest Coverage Ratio (QoQ) (2010 - 2026)
China Pharma Holdings (CPHI) Interest Coverage Ratio (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | China Pharma Holdings | 42.13 Mn | 41.82 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.10% |
| Dec 31, 2025 | -2,416.83% |
| Sep 30, 2025 | 90.69% |
| Jun 30, 2025 | -20.39% |
| Mar 31, 2025 | -109.81% |
| Dec 31, 2024 | 635.68% |
| Sep 30, 2024 | 25.41% |
| Jun 30, 2024 | -72.92% |
| Mar 31, 2024 | -952.62% |
| Dec 31, 2023 | 14,424.40% |
| Sep 30, 2023 | 99.01% |
| Jun 30, 2023 | 33.75% |
| Mar 31, 2023 | 78.05% |
| Dec 31, 2022 | 33.62% |
| Sep 30, 2022 | -1,011.04% |
| Jun 30, 2022 | 190.20% |
| Mar 31, 2022 | 31.20% |
| Dec 31, 2021 | -22,530.97% |
| Sep 30, 2021 | -0.91% |
| Jun 30, 2021 | -5.61% |